Ovarian Cancer Detection Using Photoacoustic Flow Cytometry
January 17th, 2020
5.6K views
A protocol is presented to detect circulating ovarian tumor cells utilizing a custom-made photoacoustic flow system and targeted folic acid-capped copper sulfide nanoparticles.
Overview
This article presents a protocol for detecting circulating ovarian tumor cells using a custom-made photoacoustic flow system. The method utilizes targeted folic acid-capped copper sulfide nanoparticles to enhance detection specificity.
Key Study Components
Area of Science
- Ovarian cancer detection
- Circulating tumor cells
- Photoacoustic technology
Background
- Current clinical methods for ovarian cancer detection are nonspecific.
- There is a need for point-of-care detection of circulating tumor cells.
- The photoacoustic flow system offers improvements over existing techniques.
- Optical alignment is crucial for effective detection in the system.
Purpose of Study
- To develop a platform technology for specific ovarian cancer marker detection.
- To test ex vivo patient samples for circulating tumor cells.
- To expand the application of the photoacoustic flow system for various biomarkers.
Methods Used
- Utilization of a photoacoustic flow system for sample testing.
- Application of targeted folic acid-capped copper sulfide nanoparticles.
- Testing of patient blood samples for ovarian cancer markers.
- Ensuring proper optical alignment for accurate detection.
Main Results
- The photoacoustic flow system demonstrates improved detection capabilities.
- Specific ovarian cancer markers can be identified in blood samples.
- The method is low-cost and simple compared to current techniques.
- The system shows potential for broader clinical applications.
Conclusions
- The developed protocol enhances the detection of circulating tumor cells.
- It offers a promising alternative to existing ovarian cancer detection methods.
- The technology has the potential for application in various clinical settings.
Frequently Asked Questions
What is the main advantage of the photoacoustic flow system?
The main advantage is its ability to provide specific detection of ovarian cancer markers in a low-cost and simple manner.
How does the targeted nanoparticle system work?
The targeted nanoparticle system uses folic acid-capped copper sulfide nanoparticles to enhance the specificity of tumor cell detection.
What are circulating tumor cells?
Circulating tumor cells are cancer cells that have detached from the primary tumor and are found in the bloodstream.
Why is optical alignment important in this system?
Proper optical alignment is critical for accurately detecting targets within the photoacoustic flow cytometry system.
Can this technology be applied to other types of cancer?
Yes, the photoacoustic flow system has the potential to be adapted for detecting a wide range of biomarkers in various cancers.
Executive Industry Relevance
Current ovarian cancer detection methods lack the sensitivity and specificity needed for reliable circulating tumor cell (CTC) enumeration, limiting their utility in early metastasis monitoring and treatment response assessment. This photoacoustic flow cytometry (PAFC) approach addresses this gap by enabling specific, label-based detection of ovarian cancer cells in blood samples using folic acid-targeted nanoparticles. The system offers a low-cost, adaptable platform with potential to improve target validation and mechanistic de-risking in ovarian cancer therapeutic development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of folic acid receptor overexpression as a therapeutic target in ovarian cancer models.
- Operational Value: Provides a quantitative readout of nanoparticle-cell binding affinity to support target hypothesis testing.
- Predictive Value: Supports mechanistic de-risking by linking nanoparticle uptake to detectable photoacoustic signals in a flow-based system.
Screening & Assay Development
- Assay Readiness: Generates reproducible photoacoustic signal differences between targeted nanoparticles and controls, enabling standardized detection thresholds.
- Scalability: Utilizes a custom 3D-printed flow chamber and syringe pump system compatible with ex vivo sample processing.
- Screening Utility: Facilitates evaluation of nanoparticle targeting efficiency and specificity in ovarian cancer cell lines.
Translational & Preclinical Research
- Disease Relevance: Uses SKOV-3 ovarian cancer cells to model human CTC detection in a physiologically relevant system.
- Translational Continuity: Demonstrates nanoparticle uptake and detection capability that can be extended to patient-derived samples.
- Risk-Adjusted Advancement: Provides a preclinical tool to prioritize targeting agents based on detectable signal-to-noise ratios in complex backgrounds.
Pipeline & Workflow Integration
The PAFC method fits within the discovery continuum from target validation through assay development to preclinical screening, supporting iterative refinement of targeting strategies and detection systems.
- Discovery Biology: Supports hypothesis testing of folic acid receptor-mediated targeting in ovarian cancer through quantifiable cellular uptake and signal generation.
- Screening: Enables standardized, reproducible detection of nanoparticle-labeled cells in blood surrogates, improving assay reliability for compound or agent evaluation.
- Analytics: Delivers independent photoacoustic signal measurements per cell, allowing quantitative comparison of positive and negative controls in real time and post-acquisition.
- Translational Research: Connects in vitro nanoparticle binding to detectable signals in a flow system, bridging cell-based assays and ex vivo sample analysis.
- Enterprise Reuse: The modular 3D-printed flow system and laser-transducer setup can be adapted for other biomarkers by changing targeting agents, promoting platform reuse across projects.
Operational & Enterprise Impact
- Scientific Value: Enhances target validation confidence by providing direct, optical detection of receptor-specific nanoparticle binding in a flowing system.
- Operational Value: Combines low-cost 3D printing with accessible components (syringe pumps, transducer, laser) to improve assay standardization and lab-to-lab reproducibility.
- Strategic Value: Reduces false-positive risk in CTC detection by requiring both specific nanoparticle binding and photoacoustic signal generation, improving go/no-go decision quality.
- Portfolio Impact: Enables risk-adjusted prioritization of ovarian cancer targeting strategies based on detectable signal strength and specificity in complex backgrounds.
Implementation Considerations
- Requires expertise in nanoparticle synthesis, photoacoustic instrumentation, and optical alignment for accurate signal detection.
- Depends on access to a diode-pumped solid-state laser (1053 nm), ultrasound transducer, and field-programmable gate array-equipped oscilloscope for signal acquisition.
- Necessitates standardized protocols for nanoparticle preparation, cell incubation, and washing to minimize background signal from unbound agents.
- Requires adaptation of flow rates and optical alignment when transitioning between cell lines or sample types with varying optical or acoustic properties.
- Practical limitations include the need for bubble-free acoustic coupling and careful sealing of 3D-printed components to prevent leakage and signal attenuation.
Biopharma FAQs
Why does nanoparticle binding specificity matter for target validation in ovarian cancer?
Specific binding of folic acid-capped copper sulfide nanoparticles to SKOV-3 cells enables discrimination between target and non-target populations, supporting hypothesis validation of folic acid receptor overexpression as a therapeutic target in ovarian cancer models.
How does isolating the photoacoustic signal from labeled cells support discovery pipeline decisions?
Isolating the photoacoustic signal from nanoparticle-tagged cells versus controls enables quantitative assessment of targeting efficiency, which informs lead identification and prioritization of agents based on detectable target engagement.
What quantitative photoacoustic measurements enable comparison of targeting agent performance?
The system generates independent pixel-value columns from signal envelopes, allowing direct comparison of photoacoustic signal intensity between nanoparticle-labeled cells, PBS, and nanoparticle-only controls at defined concentrations.
Why are replication requirements important for cross-functional collaboration in assay development?
Replication of signal differences between positive and negative controls ensures assay reliability across runs and users, which is essential for standardizing screening workflows and enabling consistent data interpretation in multidisciplinary teams.
What statistical analysis capabilities are required to validate detection thresholds before implementation?
The ability to distinguish signal envelopes from labeled cells, background fluid, and free nanoparticles requires baseline subtraction and signal-to-noise ratio analysis to establish reliable detection limits for ex vivo sample testing.
